Stock A042520 HANSBIOMED CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News HansBiomed Corporation

Equities

A042520

KR7042520007

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 13/05/2024 BST 		5-day change 1st Jan Change
13,490 KRW +7.06% Intraday chart for HansBiomed Corporation +2.98% -8.11%
02-14 HansBiomed Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
2023 HansBiomed Corporation(KOSDAQ:A042520) added to S&P Global BMI Index CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HansBiomed Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023
CI
HansBiomed Corporation(KOSDAQ:A042520) added to S&P Global BMI Index
CI
HansBiomed Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
CI
HansBiomed Corporation's Equity Buyback announced on June 23, 2022, has expired with 202,283 shares, representing 2.08% for KRW 1,986.65 million.
CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on June 23, 2022.
CI
HansBiomed Corporation(KOSDAQ:A042520) dropped from S&P Global BMI Index
CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
CI
HansBiomed Corporation's Equity Buyback announced on January 17, 2022, has expired with 246,000 shares, representing 2.46% for KRW 2,962.2 million.
CI
HansBiomed Corporation announces an Equity Buyback for KRW 2,000 million worth of its shares.
CI
HansBiomed Corporation authorizes a Buyback Plan.
CI
Tranche Update on HansBiomed Corporation's Equity Buyback Plan announced on January 17, 2022.
CI
HansBiomed Corporation announces an Equity Buyback for KRW 3,000 million worth of its shares.
CI
HansBiomed Corporation authorizes a Buyback Plan.
CI
HansBiomed Corporation Auditor Raises 'Going Concern' Doubt
CI
HansBiomed Corporation announced that it has received KRW 15 billion in funding from Noh & Partners Corporation
CI
Rebirth Biotechnology Co., Ltd announced that it has received CNY 20 million in funding from HansBiomed Corporation
CI
Rebirth Biotechnology Co., Ltd announced that it expects to receive CNY 20 million in funding from HansBiomed Corporation
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A042520 Stock
  4. News HansBiomed Corporation